As of June 19, 2025, Adocia SA (ADOC.PA) reports a Forward P/E of 0.81.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Adocia SA's Forward P/E to Peers
To better understand Adocia SA's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Adocia SA (ADOC.PA) | 0.81 |
| ReNeuron Group PLC (RENE.L) | 1820.39 |
| Innate Pharma SA (IPH.PA) | 18.65 |
| Novacyt SA (ALNOV.PA) | 2.02 |
Compared to its competitors, Adocia SA's Forward P/E is lower than all peers, which may suggest undervaluation or market concerns about future earnings.